News EUROAPI

Stocks

EAPI

FR0014008VX5

Pharmaceuticals

Market Closed - Euronext Paris 16:55:00 07/09/2026 BST			5-day change	1st Jan Change
0.8450 ^EUR	-2.42%		-9.33%	-62.78%

07-30	Euroapi S.A., Q2 2026 Earnings Call, Jul 30, 2026
07-29	Euroapi S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

All News

Mentions Relevance

07-31	EUROAPI : Rapport financier semestriel 2026	PU
07-31	EUROAPI : Availability of 2026 Half-year results financial report	PU
07-31	EUROAPI_Availability of 2026 Half-year results financial report	GL
07-30	Euroapi S.A., Q2 2026 Earnings Call, Jul 30, 2026
07-29	Euroapi S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
07-29	First-Half 2026 results confirm commercial and operational resilience in a challenging market environment - Transformation progressing as planned, including the divestment of the Brindisi site	GL
07-28	Huvepharma EOOD entered into Share Purchase Agreement to acquire EUROAPI Italy SRL from Euroapi S.A..	CI
06-04	Euroapi S.A. - Shareholder/Analyst Call
05-27	Combined General Meeting of May 27, 2026	GL
05-13	Euroapi says no decision made on Brindisi site amid buyer discussions	RE
05-13	Euroapi responds to market rumors
05-13	EUROAPI statement regarding the Brindisi site	GL
04-30	EUROAPI : Availibility of preparatory documents	PU
04-30	EUROAPI : Liquidity contract May 2026	PU
04-30	EUROAPI : Liquidity Contract	PU
04-30	EUROAPI_Liquidity Contract	GL
04-29	Availabilty of 2026 AGM preparatory documents	GL
03-27	EUROAPI : Availability of the 2025 Universal Registration Document, including the Annual Financial Report	PU
03-27	EUROAPI - Availability of the 2025 Universal Registration Document	GL
03-10	Deutsche Bank slashes Euroapi price target by 50%
03-04	Euroapi S.A., 2025 Earnings Call, Mar 04, 2026
03-04	Euroapi
03-03	Euroapi Unveils Results and Outlook
03-03	EUROAPI : Full-Year 2025 results	PU
03-03	Euroapi FY Ebitda EUR 9.9 mln	RE